Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Overview

Genepharm is a Greek pharmaceutical manufacturer operating a 12,000 square metre plant in Pallini, Attica, with two production lines built to EU GMP standards. Its facilities include oncology sterile liquid dosage forms, and it hires production engineers, machine operators, in-process control staff and regulatory affairs officers. The company is headquartered in Pallini, Greece.

News

News ΝΑΥΤΕΜΠΟΡΙΚΗ 2 years ago
Genepharm: Πιστοποίηση ISO για την προστασία του περιβάλλοντος
Με την απόκτησή του από τον κορυφαίο Φορέα Πιστοποίησης TÜV HELLAS (TÜV NORD), η Genepharm επιβεβαιώνει την προσήλωσή της στη μείωση των περιβαλλοντικών
Read more
Report
News ΝΑΥΤΕΜΠΟΡΙΚΗ 3 years ago
Genepharm: Βάζει σε εφαρμογή επενδυτικό πλάνο ύψους 31,2 εκατ. ευρώ
Δανειακή σύμβαση ύψους €24,9 εκατ. μέσω του Ταμείου Ανάκαμψης υπέγραψε η Alpha Bank, για την χρηματοδότηση της GENEPHARM με στόχο τη κατασκευή μίας νέας
Read more
Report
Press release PRNewswire 7 years ago
MS Pharma Announces Acquisition of Genepharm
/PRNewswire/ -- MS Pharma, a fast growing pharmaceutical company based in Jordan and operating across the Middle East, Turkey and Africa, announced today that...
Read more
Report
News pharmabiz.com 18 years ago
Strides & Genepharm sign share acquisition agreement
Strides & Genepharm sign share acquisition agreement
Read more
Report
News The Sydney Morning Herald 18 years ago
Genepharm to acquire Strides ops
Generic pharmaceuticals firm Genepharm Australasia has agreed to acquire the Australian and Asian businesses of Strides Arcolab for about $65 million.
Read more
Report
News domain-b.com 18 years ago
Strides Arcolab acquires 17.7-per cent stake in Genepharm Australasia
Strides Arcolab acquires 17.7-per cent stake in Genepharm Australasia
Read more
Report
News The Sydney Morning Herald 19 years ago
Genepharm posts $18 million loss
Generic pharmaceuticals, vitamins and skin products company Genepharm has posted a full year loss, after a multi-million dollar write-down.
Read more
Report
News news 19 years ago
Genepharm shares rocket despite $18m loss
SHARES in Genepharm Australasia rose by 35 per cent this morning, despite the generic pharmaceuticals maker posting an annual net loss of $18 million.
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Genepharm over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
64/100
Developer tools
AutoCAD
Sign in to see how your skills match this stack Sign In

Growth

Hiring Momentum
65/100
Growing
Open positions
6
9 opened / 2 closed in 30 days
Median time-to-fill
3 days
faster than 91% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Operations
22% ▲
Field & Service
22% ▲
Industrial Engineering
22% ▲
Analytics
11% ▲
Finance
11% ▲
Public Policy
11% ▲
Activity Timeline
Added HPLC to stack Oct 2026
Added GMP to stack Oct 2026
+8 jobs in a week Oct 2026

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
1
Busiest office
Pallini
Loading the map
Headquarters Builds here Office with open vacancies Tap a pin for the office
Pallini Greece
HQ
We use cookies for a better user experience.
6 open roles 6 posted in 90 days 17% engineering
hires for Field & Service, Industrial Engineering, Analytics
18km Marathon Avenue 15351 Pallini, Greece
seen since Oct 2026 company site, job postings
Athens Greece
1 open roles 2 posted in 90 days
hires for Finance
seen since Oct 2026 job postings
Earlier presence
Pikérmi, Greece 1 open roles · last posting Oct 2026

Jobs

≈ $17k – $41k per year (Estimated) · In office · Pallini
AutoCAD
Apply
≈ $17k – $41k per year (Estimated) · In office · Pallini
Apply